Literature DB >> 1182663

Geographic pathology of occult thyroid carcinomas.

F H Fukunaga, R Yatani.   

Abstract

Thyroid glands obtained from patients in southeastern Canada, northeastern Japan, southern Poland, western Colombia, and from Japanese living in Hawaii were serially step-sectioned and examined microscopically using identical techniques and diagnostic criteria. The prevalence of occult papillary thyroid carcinoma was significantly higher in Japan (28.4%) and in Hawaiian Japanese (24.2%) when compared with Canada (6%), Poland (9.1%), and Colombia (5.6%). The carcinomas were all papillary except for a single follicular lesion from Colombia. There was no significant sex prevalence. Most of the patients were between 40 and 79 years of age, but there was no particular predominant decade. Only the Colombian series had a large number of younger patients, and they showed a slightly lower prevalence of occult carcinomas before age 40. Most papillary thyroid carcinomas grow slowly and probably remain occult for the life of the patient.

Entities:  

Mesh:

Year:  1975        PMID: 1182663     DOI: 10.1002/1097-0142(197509)36:3<1095::aid-cncr2820360338>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  53 in total

1.  Occult papillary microcarcinoma of the thyroid--a potential pitfall of fine needle aspiration cytology?

Authors:  H R Harach; E Saravia Day; S B Zusman
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

2.  Total versus hemithyroidectomy for microscopic papillary thyroid cancer.

Authors:  M Gershinsky; O Barnett-Griness; N Stein; D Hirsch; G Tzvetov; O Bardicef; J Pauker; S Grozinsky-Glasberg; S Ish-Shalom; I Slutski; I Shimon; C Benbassat
Journal:  J Endocrinol Invest       Date:  2011-09-27       Impact factor: 4.256

3.  Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

4.  Thyroid incidentaloma.

Authors:  Seema Singh; Anutosh Singh; A K Khanna
Journal:  Indian J Surg Oncol       Date:  2011-11-23

5.  Mediastinal lymph node involvement as the initial manifestation of occult thyroid cancer in the surgical treatment of lung cancer: report of a case.

Authors:  M Higashiyama; K Kodama; H Yokouchi; K Takami; K Motomura; H Inaji; H Koyama
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.

Authors:  Leo A Niemeier; Haruko Kuffner Akatsu; Chi Song; Sally E Carty; Steven P Hodak; Linwah Yip; Robert L Ferris; George C Tseng; Raja R Seethala; Shane O Lebeau; Michael T Stang; Christopher Coyne; Jonas T Johnson; Andrew F Stewart; Yuri E Nikiforov
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

7.  Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma. A case of multiple endocrine neoplasia (MEN).

Authors:  H Dralle; E Altenähr
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-02-09

8.  Thyroid cancer associated with adenomatous goiter: an analysis of the incidence and clinical factors.

Authors:  H Yamashita; S Noguchi; S Watanabe; S Uchino; H Kawamoto; M Toda; N Murakami; I Nakayama; H Yamashita
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

9.  Incidence of latent breast cancer in Japanese women.

Authors:  F Akiyama; T Iwase; M Yoshimoto; F Kasumi; G Sakamoto
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Incidental and non-incidental thyroid microcarcinoma.

Authors:  Krzysztof Kaliszewski; Beata Wojtczak; Marta Strutyńska-Karpińska; Tadeusz Łukieńczuk; Zdzisław Forkasiewicz; Paweł Domosławski
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.